Oppenheimer & Co. Inc. Acquires 2,483 Shares of Amgen Inc. (NASDAQ:AMGN)
Oppenheimer & Co. Inc. grew its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 123,638 shares of the medical research company’s stock after purchasing an additional 2,483 shares during the quarter. […]
More Stories
Capricor Therapeutics’ (CAPR) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Capricor Therapeutics (NASDAQ:CAPR – Free Report) in a research note issued...
Tesla (NASDAQ:TSLA) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says
Tesla (NASDAQ:TSLA – Get Free Report) had its price target upped by analysts at Royal Bank of Canada from $249.00...
HIVE Digital Technologies (NASDAQ:HIVE) Stock Price Expected to Rise, Northland Securities Analyst Says
HIVE Digital Technologies (NASDAQ:HIVE – Free Report) had its price target boosted by Northland Securities from $5.50 to $7.00 in...
Bristol-Myers Squibb (NYSE:BMY) Price Target Raised to $60.00
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price increased by Citigroup from $55.00 to $60.00 in a research...
Hims & Hers Health (NYSE:HIMS) Lowered to “Underperform” Rating by Bank of America
Bank of America downgraded shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to an...
Morgan Stanley Forecasts Strong Price Appreciation for Smurfit Westrock (NYSE:SW) Stock
Smurfit Westrock (NYSE:SW – Free Report) had its price objective lifted by Morgan Stanley from $60.00 to $64.00 in a...